Tandem Diabetes Care Inc. insider trading
This tab shows only the shares insiders bought or sold on the open market in the last twelve months (Form 4 codes P and S). Grants, option exercises, shares held back for tax and gifts are left out on purpose, so what is left is insiders trading at the market price like anyone else.
In the last twelve months insiders at Tandem Diabetes Care Inc. filed 2 open-market sales worth $4,356 and 0 open-market purchases, on Form 4 with the SEC. The latest: Novara Mark David, EVP & Chief Commercial Officer, sold 187 shares at $23.05 on 17 March 2026, filed 18 March 2026.
| Traded | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 17 March 2026 | Novara Mark David | EVP & Chief Commercial Officer | Sale | 187 | $23.05 | $4,310 | Form 4 |
| 5 March 2026 | Novara Mark David | EVP & Chief Commercial Officer | Sale | 2 | $22.81 | $46 | Form 4 |
A filing with several lines appears once per line.
Source
Form 4 filings on EDGAR for Tandem Diabetes Care Inc.: the company's filing index.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.